Grail (NASDAQ:GRAL) Sets New 52-Week High – Here’s What Happened

Grail, Inc. (NASDAQ:GRALGet Free Report)’s stock price hit a new 52-week high during trading on Wednesday . The company traded as high as $63.99 and last traded at $47.23, with a volume of 5368896 shares. The stock had previously closed at $55.02.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on GRAL. Morgan Stanley started coverage on Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price for the company. Wolfe Research initiated coverage on Grail in a research note on Friday, November 15th. They issued a “peer perform” rating on the stock.

View Our Latest Research Report on GRAL

Grail Trading Down 9.2 %

The company has a fifty day moving average price of $26.32 and a 200 day moving average price of $19.06.

Grail (NASDAQ:GRALGet Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping the consensus estimate of ($4.41) by $2.55. On average, sell-side analysts expect that Grail, Inc. will post -65.16 EPS for the current year.

Institutional Investors Weigh In On Grail

Institutional investors have recently bought and sold shares of the stock. FNY Investment Advisers LLC bought a new position in shares of Grail in the fourth quarter valued at approximately $26,000. Lindbrook Capital LLC purchased a new position in shares of Grail during the 4th quarter valued at $28,000. State of Tennessee Department of Treasury bought a new position in shares of Grail during the 4th quarter worth $28,000. Sterling Capital Management LLC bought a new position in Grail during the fourth quarter worth about $29,000. Finally, Wellington Shields Capital Management LLC purchased a new stake in shares of Grail during the 4th quarter valued at approximately $33,000.

About Grail

(Get Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

Featured Articles

Receive News & Ratings for Grail Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grail and related companies with MarketBeat.com's FREE daily email newsletter.